Kerr, J R · Journal of veterinary medicine. B, Infectious diseases and veterinary public health · 2005 · DOI
This study examined how parvovirus B19 might trigger chronic fatigue syndrome (CFS) in some people. Researchers found that patients with prolonged symptoms after B19 infection had high levels of inflammatory chemicals in their blood, and identified certain genetic variations that may make some people more susceptible to developing CFS after B19 infection. They also discovered that the virus may persist in the body by hiding in human genes, and found that people carrying B19 virus DNA had altered expression of several genes involved in cell structure and immune function.
This study provides mechanistic evidence that parvovirus B19 persistence may drive chronic immune activation and symptom chronicity in a subset of patients, potentially explaining the molecular basis of post-viral CFS. Understanding B19-specific genetic risk factors and gene-virus interactions offers a foundation for identifying susceptible individuals and developing targeted interventions for persistent viral-associated fatigue disorders.
This study does not establish causation between identified genetic variants and CFS development, nor does it prove that B19 persistence is the sufficient cause of CFS in all cases. The cross-sectional gene expression design cannot distinguish whether observed transcriptional changes precede infection (predisposition) or result from persistent viral infection (consequence). Findings require confirmation in larger, prospective cohorts with clinical outcome data.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →